-+ 0.00%
-+ 0.00%
-+ 0.00%

Docebo publishes Q1 2026 MD&A report for three months ended March 31, 2026

PUBT·05/08/2026 10:02:00
Listen to the news
Docebo publishes Q1 2026 MD&A report for three months ended March 31, 2026
  • Docebo Inc. published its MD&A for Q1 2026, showing revenue of USD 65.62 million, up 15% year over year, driven by upselling, higher Average Contract Value of USD 71,000, and contribution from 365Talents.
  • Annual Recurring Revenue rose to USD 248.9 million from USD 225.1 million, while an OEM partner continued to reduce subscriptions, cutting its share of ARR to 3.2% from 9.4% a year earlier.
  • Net loss was USD 1.62 million versus net income of USD 1.47 million, reflecting USD 6.16 million of restructuring costs and a USD 1.45 million foreign exchange loss; adjusted EBITDA increased to USD 10.99 million from USD 8.92 million.
  • Cash and cash equivalents fell to USD 63.19 million from USD 74.04 million; operating cash flow increased to USD 24.81 million from USD 7.95 million, while investing cash outflow rose to USD 52.31 million tied mainly to 365Talents acquisition.
  • Borrowings increased by USD 79.1 million, leaving about USD 80 million outstanding under credit facility; company repurchased 2,941,176 shares for USD 60 million in substantial issuer bid, with additional NCIB buybacks of 153,360 shares for USD 2.9 million.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Docebo Inc. published the original content used to generate this news brief on May 08, 2026, and is solely responsible for the information contained therein.